Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Loss of consciousness at onset of aneurysmal subarachnoid hemorrhage in good-grade patients.

Hendrix P, Foreman PM, Senger S, Burkhardt BW, Harrigan MR, Fisher WS 3rd, Vyas NA, Lipsky RH, Walters BC, Tubbs RS, Shoja MM, Griessenauer CJ.

Neurosurg Rev. 2019 Jul 22. doi: 10.1007/s10143-019-01142-z. [Epub ahead of print]

PMID:
31332702
2.

Haplotype analysis of SERPINE1 gene: Risk for aneurysmal subarachnoid hemorrhage and clinical outcomes.

Lin M, Griessenauer CJ, Starke RM, Tubbs RS, Shoja MM, Foreman PM, Vyas NA, Walters BC, Harrigan MR, Hendrix P, Fisher WS, Pittet JF, Mathru M, Lipsky RH.

Mol Genet Genomic Med. 2019 Aug;7(8):e737. doi: 10.1002/mgg3.737. Epub 2019 Jul 3.

3.

Association of a Functional Polymorphism in the CHRFAM7A Gene with Inflammatory Response Mediators and Neuropathic Pain after Spinal Cord Injury.

Huang W, Kabbani N, Brannan TK, Lin MK, Theiss MM, Hamilton JF, Ecklund JM, Conley YP, Vodovotz Y, Brienza D, Wagner AK, Robbins E, Sowa GA, Lipsky RH.

J Neurotrauma. 2019 Nov 1;36(21):3026-3033. doi: 10.1089/neu.2018.6200. Epub 2019 May 23.

PMID:
30924722
4.

Mice lacking the transcriptional regulator Bhlhe40 have enhanced neuronal excitability and impaired synaptic plasticity in the hippocampus.

Hamilton KA, Wang Y, Raefsky SM, Berkowitz S, Spangler R, Suire CN, Camandola S, Lipsky RH, Mattson MP.

PLoS One. 2018 May 1;13(5):e0196223. doi: 10.1371/journal.pone.0196223. eCollection 2018.

5.

PHASES score applied to a prospective cohort of aneurysmal subarachnoid hemorrhage patients.

Foreman PM, Hendrix P, Harrigan MR, Fisher WS 3rd, Vyas NA, Lipsky RH, Walters BC, Tubbs RS, Shoja MM, Griessenauer CJ.

J Clin Neurosci. 2018 Jul;53:69-73. doi: 10.1016/j.jocn.2018.04.014. Epub 2018 Apr 20.

PMID:
29685416
6.

The role of endothelial nitric oxide synthase -786 T/C polymorphism in cardiac instability following aneurysmal subarachnoid hemorrhage.

Hendrix P, Foreman PM, Harrigan MR, Fisher WS Rd, Vyas NA, Lipsky RH, Lin M, Walters BC, Tubbs RS, Shoja MM, Pittet JF, Mathru M, Griessenauer CJ.

Nitric Oxide. 2017 Dec 1;71:52-56. doi: 10.1016/j.niox.2017.10.008. Epub 2017 Oct 24.

PMID:
29079038
7.

Association of cystathionine beta-synthase polymorphisms and aneurysmal subarachnoid hemorrhage.

Hendrix P, Foreman PM, Harrigan MR, Fisher WS, Vyas NA, Lipsky RH, Lin M, Walters BC, Tubbs RS, Shoja MM, Pittet JF, Mathru M, Griessenauer CJ.

J Neurosurg. 2018 Jun;128(6):1771-1777. doi: 10.3171/2017.2.JNS162933. Epub 2017 Aug 4.

PMID:
28777022
8.

Corrigendum to 'Predictors of Shunt Insertion in Aneurysmal Subarachnoid Hemorrhage' [World Neurosurgery 98 (2017) 421-426].

Motiei-Langroudi R, Adeeb N, Foreman PM, Harrigan MR, Fisher WS 3rd, Vyas NA, Lipsky RH, Walters BC, Tubbs RS, Shoja MM, Moore JM, Gupta R, Ogilvy CS, Thomas AJ, Griessenauer CJ.

World Neurosurg. 2017 Aug;104:1043. doi: 10.1016/j.wneu.2017.06.021. Epub 2017 Jun 17. No abstract available.

PMID:
28629712
9.

Association of Plasminogen Activator Inhibitor 1 (SERPINE1) Polymorphisms and Aneurysmal Subarachnoid Hemorrhage.

Hendrix P, Foreman PM, Harrigan MR, Fisher WS 3rd, Vyas NA, Lipsky RH, Lin M, Walters BC, Tubbs RS, Shoja MM, Pittet JF, Mathru M, Griessenauer CJ.

World Neurosurg. 2017 Sep;105:672-677. doi: 10.1016/j.wneu.2017.05.175. Epub 2017 Jun 6.

PMID:
28599907
10.

Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.

Griessenauer CJ, Starke RM, Foreman PM, Hendrix P, Harrigan MR, Fisher WS, Vyas NA, Lipsky RH, Lin M, Walters BC, Pittet JF, Mathru M.

J Neurosurg. 2018 May;128(5):1311-1317. doi: 10.3171/2016.12.JNS162594. Epub 2017 May 26.

PMID:
28548598
11.

Functional human GRIN2B promoter polymorphism and variation of mental processing speed in older adults.

Jiang Y, Lin MK, Jicha GA, Ding X, McIlwrath SL, Fardo DW, Broster LS, Schmitt FA, Kryscio R, Lipsky RH.

Aging (Albany NY). 2017 Apr;9(4):1293-1306. doi: 10.18632/aging.101228.

12.

Endothelin polymorphisms as a risk factor for cerebral aneurysm rebleeding following aneurysmal subarachnoid hemorrhage.

Foreman PM, Starke RM, Hendrix P, Harrigan MR, Fisher WS Rd, Vyas NA, Lipsky RH, Lin M, Walters BC, Pittet JF, Mathru M, Griessenauer CJ.

Clin Neurol Neurosurg. 2017 Jun;157:65-69. doi: 10.1016/j.clineuro.2017.04.007. Epub 2017 Apr 7.

PMID:
28412541
13.

Associations of Endothelin Polymorphisms and Aneurysm Size at Time of Rupture.

Hendrix P, Foreman PM, Starke RM, Harrigan MR, Fisher WS 3rd, Vyas NA, Lipsky RH, Lin M, Walters BC, Tubbs RS, Shoja MM, Pittet JF, Mathru M, Griessenauer CJ.

World Neurosurg. 2017 Jun;102:253-257. doi: 10.1016/j.wneu.2017.03.041. Epub 2017 Mar 18.

PMID:
28323184
14.

Endothelial Nitric Oxide Synthase Polymorphism Is Associated with Delayed Cerebral Ischemia Following Aneurysmal Subarachnoid Hemorrhage.

Hendrix P, Foreman PM, Harrigan MR, Fisher WS 3rd, Vyas NA, Lipsky RH, Lin M, Walters BC, Tubbs RS, Shoja MM, Pittet JF, Mathru M, Griessenauer CJ.

World Neurosurg. 2017 May;101:514-519. doi: 10.1016/j.wneu.2017.02.062. Epub 2017 Feb 22.

PMID:
28254540
15.

Impact of High-Mobility Group Box 1 Polymorphism on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.

Hendrix P, Foreman PM, Harrigan MR, Fisher WS Rd, Vyas NA, Lipsky RH, Lin M, Walters BC, Tubbs RS, Shoja MM, Pittet JF, Mathru M, Griessenauer CJ.

World Neurosurg. 2017 May;101:325-330. doi: 10.1016/j.wneu.2017.01.121. Epub 2017 Feb 10.

PMID:
28189859
16.

Association of renin-angiotensin system genetic polymorphisms and aneurysmal subarachnoid hemorrhage.

Griessenauer CJ, Tubbs RS, Foreman PM, Chua MH, Vyas NA, Lipsky RH, Lin M, Iyer R, Haridas R, Walters BC, Chaudry S, Malieva A, Wilkins S, Harrigan MR, Fisher WS, Shoja MM.

J Neurosurg. 2018 Jan;128(1):86-93. doi: 10.3171/2016.9.JNS161593. Epub 2017 Jan 20.

PMID:
28106497
17.

Ryanodine Receptor 1 Polymorphism Is Not Associated with Aneurysmal Subarachnoid Hemorrhage or its Clinical Sequelae.

Hendrix P, Foreman PM, Harrigan MR, Fisher WS Rd, Vyas NA, Lipsky RH, Lin M, Walters BC, Tubbs RS, Shoja MM, Pittet JF, Mathru M, Griessenauer CJ.

World Neurosurg. 2017 Apr;100:190-194. doi: 10.1016/j.wneu.2016.12.132. Epub 2017 Jan 10.

PMID:
28087430
18.

Predictors of Shunt Insertion in Aneurysmal Subarachnoid Hemorrhage.

Motiei-Langroudi R, Adeeb N, Foreman PM, Harrigan MR, Fisher WS Rd, Vyas NA, Lipsky RH, Walters BC, Tubbs RS, Shoja MM, Moore JM, Gupta R, Ogilvy CS, Thomas AJ, Griessenauer CJ.

World Neurosurg. 2017 Feb;98:421-426. doi: 10.1016/j.wneu.2016.11.092. Epub 2016 Nov 24. Erratum in: World Neurosurg. 2017 Aug;104:1043. Tubbs, Shane R [corrected to Tubbs, R Shane].

PMID:
27890755
19.

Associations of renin-angiotensin system genetic polymorphisms and clinical course after aneurysmal subarachnoid hemorrhage.

Griessenauer CJ, Tubbs RS, Foreman PM, Chua MH, Vyas NA, Lipsky RH, Lin M, Iyer R, Haridas R, Walters BC, Chaudry S, Malieva A, Wilkins S, Harrigan MR, Fisher WS 3rd, Shoja MM.

J Neurosurg. 2017 May;126(5):1585-1597. doi: 10.3171/2016.4.JNS16409. Epub 2016 Jun 10.

PMID:
27285537
20.

Association of nosocomial infections with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.

Foreman PM, Chua M, Harrigan MR, Fisher WS 3rd, Vyas NA, Lipsky RH, Walters BC, Tubbs RS, Shoja MM, Griessenauer CJ.

J Neurosurg. 2016 Dec;125(6):1383-1389. Epub 2016 Feb 12.

PMID:
26871202
21.

Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic?

Blondeau N, Lipsky RH, Bourourou M, Duncan MW, Gorelick PB, Marini AM.

Biomed Res Int. 2015;2015:519830. doi: 10.1155/2015/519830. Epub 2015 Feb 19. Review.

22.

Genetic predictors of outcome following traumatic brain injury.

Lipsky RH, Lin M.

Handb Clin Neurol. 2015;127:23-41. doi: 10.1016/B978-0-444-52892-6.00003-9. Review.

PMID:
25702208
23.

Epigenetics of depression.

Lolak S, Suwannarat P, Lipsky RH.

Prog Mol Biol Transl Sci. 2014;128:103-37. doi: 10.1016/B978-0-12-800977-2.00005-X. Review.

PMID:
25410543
24.
25.

CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response.

Martínez-Llordella M, Esensten JH, Bailey-Bucktrout SL, Lipsky RH, Marini A, Chen J, Mughal M, Mattson MP, Taub DD, Bluestone JA.

J Exp Med. 2013 Jul 29;210(8):1603-19. doi: 10.1084/jem.20122387. Epub 2013 Jul 22.

26.

Epigenetic mechanisms regulating learning and long-term memory.

Lipsky RH.

Int J Dev Neurosci. 2013 Oct;31(6):353-8. doi: 10.1016/j.ijdevneu.2012.10.110. Epub 2012 Nov 6. Review.

PMID:
23142272
27.

Oxytocin receptor genetic variation promotes human trust behavior.

Krueger F, Parasuraman R, Iyengar V, Thornburg M, Weel J, Lin M, Clarke E, McCabe K, Lipsky RH.

Front Hum Neurosci. 2012 Feb 2;6:4. doi: 10.3389/fnhum.2012.00004. eCollection 2012.

28.

BDNF polymorphism-dependent OFC and DLPFC plasticity differentially moderates implicit and explicit bias.

Forbes CE, Poore JC, Barbey AK, Krueger F, Solomon J, Lipsky RH, Hodgkinson CA, Goldman D, Grafman J.

Cereb Cortex. 2012 Nov;22(11):2602-9. doi: 10.1093/cercor/bhr337. Epub 2011 Nov 28.

29.

Cellular and molecular responses of cultured neurons to stressful stimuli.

Chen J, Pan H, Lipsky RH, Pérez-Gómez A, Cabrera-Garcia D, Fernández-Sánchez MT, Novelli A, Marini AM.

Dose Response. 2011;9(3):416-33. doi: 10.2203/dose-response.10-041.Marini. Epub 2011 Feb 22.

30.

The role of the Met66 brain-derived neurotrophic factor allele in the recovery of executive functioning after combat-related traumatic brain injury.

Krueger F, Pardini M, Huey ED, Raymont V, Solomon J, Lipsky RH, Hodgkinson CA, Goldman D, Grafman J.

J Neurosci. 2011 Jan 12;31(2):598-606. doi: 10.1523/JNEUROSCI.1399-10.2011.

31.

Effects of histone deacetylase inhibitor Trichostatin A on epigenetic changes and transcriptional activation of Bdnf promoter 1 by rat hippocampal neurons.

Tian F, Marini AM, Lipsky RH.

Ann N Y Acad Sci. 2010 Jun;1199:186-93. doi: 10.1111/j.1749-6632.2009.05175.x.

PMID:
20633124
32.

Differential actions of ethanol and trichloroethanol at sites in the M3 and M4 domains of the NMDA receptor GluN2A (NR2A) subunit.

Salous AK, Ren H, Lamb KA, Hu XQ, Lipsky RH, Peoples RW.

Br J Pharmacol. 2009 Nov;158(5):1395-404. doi: 10.1111/j.1476-5381.2009.00397.x. Epub 2009 Sep 25.

33.

Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: a versatile potential therapy for stroke.

Blondeau N, Nguemeni C, Debruyne DN, Piens M, Wu X, Pan H, Hu X, Gandin C, Lipsky RH, Plumier JC, Marini AM, Heurteaux C.

Neuropsychopharmacology. 2009 Nov;34(12):2548-59. doi: 10.1038/npp.2009.84. Epub 2009 Jul 29.

34.

NMDA receptor activation induces differential epigenetic modification of Bdnf promoters in hippocampal neurons.

Tian F, Marini AM, Lipsky RH.

Amino Acids. 2010 Apr;38(4):1067-74. doi: 10.1007/s00726-009-0315-y. Epub 2009 Jun 30.

35.

Dynamic chromatin remodeling events in hippocampal neurons are associated with NMDA receptor-mediated activation of Bdnf gene promoter 1.

Tian F, Hu XZ, Wu X, Jiang H, Pan H, Marini AM, Lipsky RH.

J Neurochem. 2009 Jun;109(5):1375-88. doi: 10.1111/j.1471-4159.2009.06058.x. Epub 2009 Mar 23.

36.

Molecular differentiation of schizoaffective disorder from schizophrenia using BDNF haplotypes.

Lencz T, Lipsky RH, DeRosse P, Burdick KE, Kane JM, Malhotra AK.

Br J Psychiatry. 2009 Apr;194(4):313-8. doi: 10.1192/bjp.bp.108.050401.

37.

Brain adaptation to stressful stimuli: a new perspective on potential therapeutic approaches based on BDNF and NMDA receptors.

Marini AM, Popolo M, Pan H, Blondeau N, Lipsky RH.

CNS Neurol Disord Drug Targets. 2008 Oct;7(4):382-90. Review.

PMID:
18991667
38.

Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution.

Jiang X, Zhou J, Mash DC, Marini AM, Lipsky RH.

Neuromolecular Med. 2009;11(1):1-12. doi: 10.1007/s12017-008-8051-0. Epub 2008 Oct 23.

PMID:
18946637
39.

A missense variant (P10L) of the melanopsin (OPN4) gene in seasonal affective disorder.

Roecklein KA, Rohan KJ, Duncan WC, Rollag MD, Rosenthal NE, Lipsky RH, Provencio I.

J Affect Disord. 2009 Apr;114(1-3):279-85. doi: 10.1016/j.jad.2008.08.005. Epub 2008 Sep 18.

40.

Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.

Crowley JJ, Lipsky RH, Lucki I, Berrettini WH.

Psychiatr Genet. 2008 Oct;18(5):248-51. doi: 10.1097/YPG.0b013e3283052ff7.

PMID:
18797399
41.

CRH haplotype as a factor influencing cerebrospinal fluid levels of corticotropin-releasing hormone, hypothalamic-pituitary-adrenal axis activity, temperament, and alcohol consumption in rhesus macaques.

Barr CS, Dvoskin RL, Yuan Q, Lipsky RH, Gupte M, Hu X, Zhou Z, Schwandt ML, Lindell SG, McKee M, Becker ML, Kling MA, Gold PW, Higley D, Heilig M, Suomi SJ, Goldman D.

Arch Gen Psychiatry. 2008 Aug;65(8):934-44. doi: 10.1001/archpsyc.65.8.934.

42.

Additional functional variation at the SLC6A4 gene.

Lipsky RH, Hu XZ, Goldman D.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):153. doi: 10.1002/ajmg.b.30766. No abstract available.

43.

Genetic variation in human NPY expression affects stress response and emotion.

Zhou Z, Zhu G, Hariri AR, Enoch MA, Scott D, Sinha R, Virkkunen M, Mash DC, Lipsky RH, Hu XZ, Hodgkinson CA, Xu K, Buzas B, Yuan Q, Shen PH, Ferrell RE, Manuck SB, Brown SM, Hauger RL, Stohler CS, Zubieta JK, Goldman D.

Nature. 2008 Apr 24;452(7190):997-1001. doi: 10.1038/nature06858. Epub 2008 Apr 2.

44.

BHLHB2 controls Bdnf promoter 4 activity and neuronal excitability.

Jiang X, Tian F, Du Y, Copeland NG, Jenkins NA, Tessarollo L, Wu X, Pan H, Hu XZ, Xu K, Kenney H, Egan SE, Turley H, Harris AL, Marini AM, Lipsky RH.

J Neurosci. 2008 Jan 30;28(5):1118-30. doi: 10.1523/JNEUROSCI.2262-07.2008.

45.

Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity.

Lipsky RH, Marini AM.

Ann N Y Acad Sci. 2007 Dec;1122:130-43. Review.

PMID:
18077569
46.

Hormesis: a promising strategy to sustain endogenous neuronal survival pathways against neurodegenerative disorders.

Marini AM, Jiang H, Pan H, Wu X, Lipsky RH.

Ageing Res Rev. 2008 Jan;7(1):21-33. Epub 2007 Aug 24. Review.

PMID:
17889623
47.

Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.

Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paddock S, McMahon FJ, Manji H, Lipsky RH.

Arch Gen Psychiatry. 2007 Jul;64(7):783-92.

PMID:
17606812
48.

Mutations at F637 in the NMDA receptor NR2A subunit M3 domain influence agonist potency, ion channel gating and alcohol action.

Ren H, Salous AK, Paul JM, Lipsky RH, Peoples RW.

Br J Pharmacol. 2007 Jul;151(6):749-57. Epub 2007 May 21.

49.

Nucleotide sequence variation within the human tyrosine kinase B neurotrophin receptor gene: association with antisocial alcohol dependence.

Xu K, Anderson TR, Neyer KM, Lamparella N, Jenkins G, Zhou Z, Yuan Q, Virkkunen M, Lipsky RH.

Pharmacogenomics J. 2007 Dec;7(6):368-79. Epub 2007 Jan 2.

50.

Preconditioning and neurotrophins: a model for brain adaptation to seizures, ischemia and other stressful stimuli.

Marini AM, Jiang X, Wu X, Pan H, Guo Z, Mattson MP, Blondeau N, Novelli A, Lipsky RH.

Amino Acids. 2007;32(3):299-304. Epub 2006 Sep 29. Review.

PMID:
16998712

Supplemental Content

Loading ...
Support Center